Sign In
Buy DARE
$2.05
-0.0900 (-4.21%)
At Close: Jun 03, 2026
Can Your Depression Medication Affect Your Sex Life?
02:10pm, Wednesday, 17'th Jun 2020
Here’s the answer.
Daré Bioscience Announces Initiation of Pivotal Phase 3 Study of DARE-BV1 in Patients with Bacterial Vaginosis
12:00pm, Wednesday, 17'th Jun 2020
Daré Bioscience, Inc. (DARE), a leader in women’s health innovation, today announced the initiation of the DARE-BVFREE study, a multi-center, double-blind, placebo-controlled Phase 3 clinical study
Daré Bioscience, Inc. (DARE), a leader in women’s health innovation, today announced the receipt by its wholly owned subsidiary of $1.5 million in additional grant funding from the Bill & Melinda G
Daré Bioscience Announces Participation in BIO Digital 2020
12:00pm, Thursday, 04'th Jun 2020
Daré Bioscience, Inc. (DARE), a leader in women’s health innovation, today announced that the company will participate in the BIO International Convention, which will be held in a new, virtual eve
Edited Transcript of DARE earnings conference call or presentation 14-May-20 8:30pm GMT
07:02pm, Sunday, 17'th May 2020
Q1 2020 Dare Bioscience Inc Earnings Call
Daré Bioscience Reports First Quarter 2020 Financial Results and Provides Company Update
12:00pm, Thursday, 14'th May 2020
Daré Bioscience, Inc. (DARE), a leader in women’s health innovation, today reported financial results for the first quarter ended March 31, 2020 and provided a company update. “The first quarte
Daré Bioscience, Inc. (DARE), a leader in women’s health innovation, and Health Decisions, Inc., a full-service contract research organization (CRO) specializing in women’s health clinical resear
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
Daré Bioscience to Host First Quarter 2020 Financial Results and Company Update Conference Call and Webcast on May 14, 2020
12:00pm, Thursday, 07'th May 2020
Daré Bioscience, Inc. (DARE), a leader in women’s health innovation, today announced that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Thursday, May 14, 2020, to
BBBY, DVAX among premarket gainers
01:22pm, Tuesday, 28'th Apr 2020
Broadwind Energy (NASDAQ:BWEN) +60%. on $19M order.TrovaGene (NASDAQ:TROV) +44% on new positive results from its ongoing Phase 1b/2 clinical trial of onvansertib in combination with FOLFIRI and Avast
Daré Bioscience CEO to Participate in Maxim Group’s Infectious Disease Virtual Conference
12:00pm, Tuesday, 28'th Apr 2020
Daré Bioscience, Inc.(DARE), a leader in women’s health innovation, today announced that Sabrina Martucci Johnson, President and Chief Executive Officer, will participate in a panel discussion dur
Wells softens view on Edwards Lifesciences in premarket analyst action
11:32am, Tuesday, 28'th Apr 2020
Adverum Biotechnologies (NASDAQ:ADVM) initiated with Buy rating and $17 (36% upside) price target at Goldman Sachs.Alector (NASDAQ:ALEC) initiated with Buy rating and $32 (21% upside) price target at
34 Stocks Moving in Tuesday's Pre-Market Session
11:16am, Tuesday, 28'th Apr 2020
Gainers
Document Security Systems, Inc. (NYSE: DSS) shares rose 43.8% to $0.43 in pre-market trading after the company reported completion of required independent valuation,...
Anika Names Cheryl R. Blanchard, Ph.D., as President and Chief Executive Officer
12:30pm, Monday, 27'th Apr 2020
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid (HA) technology platform, t
Daré Bioscience Announces Common Stock Purchase Agreement for up to $15 Million with Lincoln Park Capital Fund, LLC
12:00pm, Thursday, 23'rd Apr 2020
Daré Bioscience, Inc. (DARE), a leader in women’s health innovation, today announced it entered into a $15 million common stock purchase agreement and registration rights agreement with Lincoln P
